Reaching Un-Drugable Intracellular Targets with the Long Arm of Antibodies
Reaching Un-Drugable Intracellular Targets with the Long Arm of Antibodies |
|
https://doi.org/10.18632/oncotarget.1039
David A. Scheinberg,
Tao Dao,
and Cheng Liu
|
| 647-648 |
Perturbation of nucleotide metabolism - the driving force of oncogene-induced senescence
Perturbation of nucleotide metabolism - the driving force of oncogene-induced senescence |
|
https://doi.org/10.18632/oncotarget.1023
Zbigniew Darzynkiewicz
|
| 649-650 |
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells |
|
https://doi.org/10.18632/oncotarget.1040
Ilia A. Droujinine,
Mark A Eckert,
and Weian Zhao
|
| 651-664 |
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1 |
|
https://doi.org/10.18632/oncotarget.928
Ariel Bier,
Niss Giladi,
Noam Kronfeld,
Hae Kyung Lee,
Simona Cazacu,
Susan Finniss,
Cunli Xiang,
Laila Poisson,
Ana C deCarvalho,
Shimon Slavin,
Elad Jacoby,
Michal Yalon,
Amos Toren,
Tom Mikkelsen,
and Chaya Brodie
|
| 665-676 |
Cell death sensitization of leukemia cells by opioid receptor activation
Cell death sensitization of leukemia cells by opioid receptor activation |
|
https://doi.org/10.18632/oncotarget.952
Claudia Friesen,
Mareike Roscher,
Inis Hormann,
Iduna Fichtner,
Andreas Alt,
Ralf Hilger,
Klaus-Michael Debatin,
and Erich Miltner
|
| 677-690 |
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors |
|
https://doi.org/10.18632/oncotarget.975
Joanna L Gillis,
Luke A Selth,
Margaret M Centenera,
Scott L Townley,
Shihua Sun,
Stephen R Plymate,
Wayne D Tilley,
and Lisa M Butler
|
| 691-704 |
P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy
P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy |
|
https://doi.org/10.18632/oncotarget.974
Rabih Said,
David S. Hong,
Carla L. Warneke,
J. Jack Lee,
Jennifer J. Wheler,
Filip Janku,
Aung Naing,
Gerald S. Falchook,
Siqing Fu,
Sarina Piha-Paul,
Apostolia M. Tsimberidou,
and Razelle Kurzrock
|
| 705-714 |
Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations
Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations |
|
https://doi.org/10.18632/oncotarget.990
Jonathan M. Gerber,
Jessica L. Gucwa,
David Esopi,
Meltem Gurel,
Michael C. Haffner,
Milada Vala,
William G. Nelson,
Richard J. Jones,
and Srinivasan Yegnasubramanian
|
| 715-728 |
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies. |
|
https://doi.org/10.18632/oncotarget.1027
Rocky Cipriano,
Kristy L.S. Miskimen,
Benjamin L. Bryson,
Chase R. Foy,
Courtney A. Bartel,
and Mark W Jackson
|
| 729-738 |
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer |
|
https://doi.org/10.18632/oncotarget.1034
Xiao-Yang Wang,
Huina Yu,
R. Ilona Linnpoila,
Laodong Li,
Dangyu Li,
Biwen Bo,
Hideyuki Okano,
Luis O.F. Penalva,
and Robert I Glazer
|
| 739-750 |
Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108
Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108 |
|
https://doi.org/10.18632/oncotarget.1044
Karoly Szepeshazi,
Andrew V. Schally,
Norman L. Block,
Gabor Halmos,
Mehrdad Nadji,
Luca Szalontay,
Irving Vidaurre,
Andrew Abi-Chaker,
and Ferenc G. Rick
|
| 751-760 |
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma |
|
https://doi.org/10.18632/oncotarget.1047
Ryan T Pitman,
Luke Wojdyla,
and Neelu Puri
|
| 761-771 |
Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population |
|
https://doi.org/10.18632/oncotarget.1028
Jennifer Wheler,
Gerald Falchook,
Apostolia M. Tsimberidou,
David Hong,
Aung Naing,
Sarina Piha-Paul,
Su S. Chen,
John Heymach,
Siqing Fu,
Su S. Chen,
Bettzy Stephen,
Jansina Y. Fok,
Filip Janku,
and Razelle Kurzrock
|
| 772-784 |
CD44variant exon 9 plays an important role in colon cancer initiating cells
CD44variant exon 9 plays an important role in colon cancer initiating cells |
|
https://doi.org/10.18632/oncotarget.1048
Youhei Kimura,
Takanori Goi,
Toshiyuki Nakazawa,
Yasuo Hirono,
Kanji Katayama,
Takeshi Urano,
and Akio Yamaguchi
|
| 785-791 |
Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts
Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts |
|
https://doi.org/10.18632/oncotarget.1059
Dominique M. Higgins,
Ruisi Wang,
Brian Milligan,
Mark Schroeder,
Brett Carlson,
Jenny Pokorny,
Samuel H. Cheshier,
Fredric B. Meyer,
Irving L. Weissman,
Jann N. Sarkaria,
and John R. Henley
|
| 792-801 |
